UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Volltextzugriff (PDF)

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Volltextzugriff (PDF)

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

International journal of antimicrobial agents, 2011-07, Vol.38 (1), p.65-69

2011

Volltextzugriff (PDF)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4465-4468

2011

Volltextzugriff (PDF)

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1065-1068

2013

Volltextzugriff (PDF)

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Volltextzugriff (PDF)

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.352-357

2012

Volltextzugriff (PDF)

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Volltextzugriff (PDF)

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Volltextzugriff (PDF)

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Clinical infectious diseases, 2001-07, Vol.33 (2), p.177-186

2001

Volltextzugriff (PDF)

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3965-3968

2012

Volltextzugriff (PDF)

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5155-5158

2011

Volltextzugriff (PDF)

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.239-244

1999

Volltextzugriff (PDF)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Volltextzugriff (PDF)

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1724-1732

2013

Volltextzugriff (PDF)

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Clinical infectious diseases, 2004-01, Vol.38 (1), p.78-85

2004

Volltextzugriff (PDF)

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1762-1770

1998

Volltextzugriff (PDF)

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

Infection control and hospital epidemiology, 2006-12, Vol.27 (12), p.1291-1298

2006

Volltextzugriff (PDF)

Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility

Clinical infectious diseases, 2000-09, Vol.31 (3), p.690-697

2000

Volltextzugriff (PDF)

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1543-1548

2011

Volltextzugriff (PDF)

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2223-2227

2004

Volltextzugriff (PDF)

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Clinical infectious diseases, 2013-06, Vol.56 (11), p.1614-1620

2013

Volltextzugriff (PDF)

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Antimicrobial Agents and Chemotherapy, 1998-05, Vol.42 (5), p.1207-1212

1998

Volltextzugriff (PDF)

Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy, 1999-02, Vol.43 (2), p.385-389

1999

Volltextzugriff (PDF)

Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections

Diagnostic microbiology and infectious disease, 2007-12, Vol.59 (4), p.407-414

2007

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Aktive Filter

ThemaMycology

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(204)

Publikationsform

Artikel
(234)
Bücher
(1)

Sprache

Englisch
(235)
Japanisch
(38)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(234)
Life Sciences & Biomedicine
(199)
Science & Technology
(199)
Microbiology
(167)
Humans
(164)
Infectious Diseases
(160)
Pharmacology. Drug Treatments
(145)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(140)
Microbial Sensitivity Tests
(105)
Antibacterial Agents
(80)
Antifungal Agents - Pharmacology
(52)
Anti-Bacterial Agents - Pharmacology
(50)
Antifungal Agents
(50)
Pharmacology & Pharmacy
(50)
Epidemiology
(43)
Infections
(42)
Bacterial Diseases
(40)
Female
(40)
Human Bacterial Diseases
(39)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Has Antifungal Susceptibility Testing Come of Age?

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections

Aktive Filter

Suchergebnisse filtern